Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about LXR: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | LXR |
| Aliases | Liver X Receptor |
| Pathways | NF-κB |
| GeneCards | LXR |
| Human Protein Atlas | LXR |
| Associated Diseases | ALS, Alzheimer, glioblastoma, neurodegeneration |
| Known Drugs/Compounds | rapamycin |
| Interactions | ABCA1, ABCA7, ABCG1, ACAT1, AKT, AMPK |
| SciDEX Hypotheses | Upstream restoration of glial lipid efflux and apo |
| KG Connections | 103 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
LXR(["LXR"])
CD38(["CD38"])
S1PR1["S1PR1"]
Kupffer_Cell_Survival("Kupffer Cell Survival")
Cholesterol_Efflux("Cholesterol Efflux")
S1P1["S1P1"]
AP_1(["AP-1"])
SREBP1["SREBP1"]
Metabolic_Stress("Metabolic Stress")
KUPFFER_CELLS["KUPFFER_CELLS"]
LXR -->|"upregulates"| CD38
S1PR1 -->|"activates"| LXR
LXR -->|"regulates"| Kupffer_Cell_Survival
LXR -->|"regulates"| Cholesterol_Efflux
S1P1 -->|"upregulates"| LXR
AP_1 -->|"modulates"| LXR
LXR -->|"regulates"| SREBP1
Metabolic_Stress -->|"activates"| LXR
LXR -->|"regulates"| KUPFFER_CELLS
style LXR fill:#1a237e,stroke:#4fc3f7,stroke-width:3px,color:#fff| Target | Relation | Type | Str |
|---|---|---|---|
| oxidative stress response | participates_in | pathway | 0.90 |
| Cholesterol Efflux | regulates | process | 0.85 |
| Kupffer Cell Survival | regulates | process | 0.85 |
| cholesterol homeostasis | participates_in | pathway | 0.85 |
| TAU | regulates | protein | 0.80 |
| APOE4 | regulates | protein | 0.80 |
| SREBP1 | regulates | entity | 0.80 |
| unfolded protein response | participates_in | pathway | 0.75 |
| lipid metabolism | participates_in | pathway | 0.70 |
| neuroinflammation | activates | disease | 0.65 |
| ubiquitin-proteasome | participates_in | pathway | 0.60 |
| Alzheimer's disease | inhibits | disease | 0.60 |
| neurodegeneration | inhibits | disease | 0.60 |
| MAF | activates | gene | 0.60 |
| cardiovascular disease | activates | disease | 0.60 |
| T cells | expressed_in | cell_type | 0.60 |
| TREM2 | inhibits | gene | 0.60 |
| neurodegeneration | protects_against | disease | 0.60 |
| oligodendrocytes | expressed_in | cell_type | 0.60 |
| TNF | expressed_in | gene | 0.60 |
| PPAR | regulates | gene | 0.60 |
| cardiovascular disease | regulates | disease | 0.60 |
| Alzheimer's disease | activates | disease | 0.60 |
| Alzheimer's disease | expressed_in | disease | 0.60 |
| ALS | associated_with | disease | 0.60 |
| Alzheimer | associated_with | disease | 0.60 |
| neurodegeneration | associated_with | disease | 0.60 |
| apoptosis pathway | participates_in | pathway | 0.60 |
| multiple sclerosis | activates | disease | 0.60 |
| MAPK | activates | gene | 0.60 |
| PKA | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| neurodegeneration | regulates | disease | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| pyroptosis | participates_in | pathway | 0.60 |
| senescence | participates_in | pathway | 0.60 |
| PPAR | activates | gene | 0.60 |
| neurodegeneration | activates | disease | 0.60 |
| blood-brain barrier | participates_in | pathway | 0.60 |
| MAPK signaling | participates_in | pathway | 0.60 |
| epigenetic regulation | participates_in | pathway | 0.60 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.60 |
| RNA | inhibits | gene | 0.60 |
| glioblastoma | inhibits | disease | 0.60 |
| glioblastoma | associated_with | disease | 0.60 |
| KUPFFER_CELLS | regulates | cell_type | 0.56 |
| macrophages | expressed_in | cell_type | 0.55 |
| TREM2 | protects_against | gene | 0.55 |
| SGMS1 | expressed_in | gene | 0.55 |
| TREM2 | associated_with | gene | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| 29563219 | regulates transcription of | paper | 0.90 |
| AP-1 | modulates | protein | 0.85 |
| S1P1 | upregulates | receptor | 0.85 |
| APOE | expressed_in | gene | 0.70 |
| ATP | activates | gene | 0.70 |
| ABCA1 | activates | gene | 0.65 |
| CYP46A1 | activates | gene | 0.65 |
| APOE | associated_with | gene | 0.65 |
| ACAT1 | activates | gene | 0.60 |
| APP | expressed_in | gene | 0.60 |
| APOE4 | activates | gene | 0.60 |
| APOE | regulates | gene | 0.60 |
| AQP4 | regulates | gene | 0.60 |
| ABCA1 | inhibits | gene | 0.60 |
| IRF8 | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| rapamycin | targets | drug | 0.60 |
| LDL | activates | gene | 0.60 |
| ABCA1 | associated_with | gene | 0.60 |
| LRP1 | activates | gene | 0.60 |
| GBM | inhibits | gene | 0.60 |
| ACAT1 | inhibits | gene | 0.60 |
| GAS6 | regulates | gene | 0.60 |
| ABCA1 | regulates | gene | 0.60 |
| ABCA7 | regulates | gene | 0.60 |
| ABCG1 | regulates | gene | 0.60 |
| ABCA1 | expressed_in | gene | 0.60 |
| ABCA7 | expressed_in | gene | 0.60 |
| ABCG1 | expressed_in | gene | 0.60 |
| GAS6 | expressed_in | gene | 0.60 |
| ABCA7 | activates | gene | 0.60 |
| ABCG1 | activates | gene | 0.60 |
| GAS6 | activates | gene | 0.60 |
| APOE | protects_against | gene | 0.55 |
| APOE | activates | gene | 0.55 |
| APP | activates | gene | 0.55 |
| DGAT1 | activates | gene | 0.55 |
| GBM | co_expressed_with | gene | 0.50 |
| HMGCR | co_expressed_with | gene | 0.50 |
| LDLR | co_expressed_with | gene | 0.50 |
| CYP46A1 | co_expressed_with | gene | 0.50 |
| APOE3 | co_expressed_with | protein | 0.50 |
| APOE4 | co_expressed_with | gene | 0.50 |
| ABCA7 | co_expressed_with | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning LXR in their description or question text
Score: 0.000 · lipidomics · 2026-04-27
This hypothesis proposes that LXRβ-selective agonists enhance CYP2J2 expression and activity to increase protective DHA
Score: 0.000 · lipidomics · 2026-04-27
This hypothesis proposes that selective activation of LXRα (NR1H3) represents a superior therapeutic approach for addres
Score: 0.000 · lipidomics · 2026-04-26
This hypothesis proposes that selective LXRβ agonism primarily functions through transcriptional upregulation of ABCA1 (
Score: 0.000 · lipidomics · 2026-04-26
This hypothesis proposes that CYP2J2-generated DHA epoxides act as endogenous LXRβ agonists, creating a synergistic mech